Fabien V. K. Diomandé

发表

Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt

Michael L. Jackson, Isaïe Medah, Ryan T Novak, 2013, PloS one.

Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013

F. Diomandé, M. Djingarey, M. Préziosi, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.

Sarah A. Meyer, Ryan T Novak, K. Wannemuehler, 2015, Vaccine.

MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Africa.

Anna M. Acosta, Ryan T Novak, T. Clark, 2019, The Journal of infectious diseases.

Tuberculin skin testing to assess the occupational risk of Mycobacterium tuberculosis infection among health care workers in Abidjan, Côte d'Ivoire.

N. Binkin, S. Wiktor, A. Greenberg, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014

Ryan T Novak, W. Perea, F. Diomandé, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Ryan T Novak, L. Mayer, T. Clark, 2012, The Lancet. Infectious diseases.

Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac

D. Caugant, T. Clark, P. Kristiansen, 2014, BMC Infectious Diseases.

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.

D. Caugant, T. Clark, P. Kristiansen, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire.

M. Pallansch, M. Nolan, O. Kew, 2005, The Journal of infectious diseases.

Neisseria meningitidis Serogroup W, Burkina Faso, 2012

Ryan T Novak, L. Mayer, T. Clark, 2014, Emerging infectious diseases.

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine

D. Caugant, T. Clark, P. Kristiansen, 2011, Clinical and Vaccine Immunology.

Prevalence of genotypic and phenotypic HIV‐1 drug‐resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS–Drug Access Initiative in Abidjan, Côte d'Ivoire

K. Hertogs, B. Larder, M. Peeters, 2003, AIDS.

Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali

L. Moulton, S. Omer, N. Halsey, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaccinations and Vaccinators’ Tracking System in Island Settlements: CHAD 2017-2018

J. Okeibunor, F. Diomandé, Fabien V. K. Diomandé, 2021, Journal of immunological sciences.

The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative

M. Nolan, M. Laga, E. Bissagnéné, 2003, AIDS.

Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.

F. Diomandé, M. Djingarey, P. Zuber, 2012, Vaccine.

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.

D. Caugant, T. Clark, P. Kristiansen, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.

Ryan T Novak, S. Hugonnet, D. Caugant, 2012, Vaccine.

Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire

J. Saba, J. Nkengasong, T. Chorba, 2003, AIDS.

Carriage of Neisseria lactamica in 1- to 29-Year-Old People in Burkina Faso: Epidemiology and Molecular Characterization

D. Caugant, T. Clark, P. Kristiansen, 2012, Journal of Clinical Microbiology.

Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso.

D. Caugant, T. Clark, P. Kristiansen, 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Evaluation of acute flaccid paralysis surveillance performance before and during the 2014-2015 Ebola virus disease outbreak in Guinea and Liberia

A. Craig, T. Moon, Fabien V. K. Diomandé, 2023, The Pan African medical journal.

Response to Poliovirus Outbreaks in the Lake Chad Sub-Region: A GIS Mapping Approach

J. Okeibunor, F. Diomandé, Abdelrahim Khalid, 2021, Journal of immunological sciences.